Not medical advice. Talk to your provider before using any peptide.
Full disclaimerDerek (MPMD) GH Replication Stack
Derek's approach to replicating pharma-grade GH IGF-1 levels without actual GH. CJC-1295 DAC at 2.5mg twice weekly (Monday and Thursday) plus MK-677 at 25mg daily oral, both at bedtime. Target: IGF-1 around 500 ng/mL. The CJC-1295 DAC dose exceeds standard ranges. Regular IGF-1 bloodwork and fasting glucose monitoring required. Advanced users only.
Peptide Schedule Research TeamReviewed Apr 10, 2026
For replicating high-dose growth hormone IGF-1 levels using peptides instead of pharmaceutical GH.
What This Protocol Does
CJC-1295 with DAC at 2.5mg twice weekly (Monday and Thursday) plus MK-677 at 25mg daily (oral). Both taken at bedtime. The target is IGF-1 levels around 500 ng/mL, which approximates what you'd get from pharmaceutical growth hormone at significant doses. CJC-1295 DAC has a long half-life (6-8 days), creating sustained GH elevation. MK-677 is an oral GH secretagogue that boosts GH release through the ghrelin pathway.
Who Should Use This
Advanced users only. The CJC-1295 DAC dose (2.5mg twice weekly, 5mg total) exceeds standard dosing ranges. Requires regular IGF-1 and fasting glucose bloodwork. MK-677 increases appetite and water retention significantly, so be prepared. Not for beginners, anyone with diabetes risk, or those with elevated IGF-1. Start with the Campbell Beginner GH Stack if this is your first GH protocol.
What the Research Says
CJC-1295 with DAC has clinical data showing sustained IGF-1 elevation for 6-8 days after a single injection (Teichman et al., PMID 16352683). MK-677 (ibutamoren) has Phase 2 data showing increased GH secretion and IGF-1 levels by 40-60% at 25mg daily (Chapman et al., PMID 9467534). Derek's combined protocol targets IGF-1 levels of ~500 ng/mL, which is well above the normal reference range (100-300 ng/mL for most adults). No published studies test this specific combination at these doses.
Important Notices
- CJC-1295 DAC at 2.5mg exceeds standard dosing: advanced users only
- MK-677 can increase appetite and water retention significantly
- Monitor IGF-1 levels and fasting glucose regularly
Protocol Overview
GH Replication Combo
CJC-1295 (DAC) + MK-677 (Ibutamoren)
Both at bedtime
Recommended Labwork
- IGF-1 levels
- Fasting glucose
- HbA1c
Dosing Details
| Peptide | Dose | Frequency | Route | Weeks |
|---|---|---|---|---|
CJC-1295 (DAC)Maint. | 2.5mg | Custom Schedule | subcutaneous | Week 1+ |
MK-677 (Ibutamoren)Maint. | 25mg | Daily | oral | Week 1+ |
CJC-1295 (DAC): 2.5mg SubQ before bed Mon + Thu. Total 5mg/week. Target IGF-1 ~500 ng/mL.
MK-677 (Ibutamoren): 25mg oral daily before bed. "Diminishing returns once you pass 25mg per day."
Metrics Tracked
Ready to start this protocol?
Set your start date and track every dose in your calendar.
